Join DASON Liaison Jeannette Bouchard as she speaks with Dr. Bruce Jones and aspiring pharmacist Jill Foster, authors on an IDWeek poster that caught the attention of a few DASON liaisons. The poster was titled “Impact of Removing ‘Budding Yeast’’ From Urinalysis Reports on Fluconazole Use”. Take a listen to hear about a great local initiative that made a big impact on fluconazole use at their institution.

Link to supporting article:

In this episode of the DASON Digest podcast, DASON Clinical Pharmacist Liaison Dr. Melissa Johnson talks with Dr. Tyler Mitzner and Dr. Lisa Dumkow from Trinity Health Grand Rapids Hospital about their new publication comparing cefdinir and cephalexin for uncomplicated UTI treatment. The article can be found here: https://pubmed.ncbi.nlm.nih.gov/41141459/

For more information about DASON, please visit: https://dason.medicine.duke.edu/

In this episode, DASON Clinical Pharmacist Liaison, Dr. April Dyer, talk to us about a publication in Health Affairs Scholar, entitled "Sustainable solutions to the continuous threat of antimicrobial resistance." The article can be viewed here: https://pubmed.ncbi.nlm.nih.gov/39916975/

For more information about DASON, please visit: https://dason.medicine.duke.edu/

In this episode, DASON Clinical Pharmacist Liaison and Operations Director, Dr. Libby Dodds Ashley, talks with Duke University Hospital Clinical Pharmacist, Dr. Jenna Januszka about the recent ICHE publication "2025 US Public Health Service Guidelines for the Management of Occupational Exposures to Human Immunodeficiency Virus and Recommendations for Post-exposure Prophylaxis in Healthcare Settings."

For more information about DASON, please visit: https://dason.medicine.duke.edu/

In this episode of the DASON Digest podcast, DASON Clinical Pharmacist Liaison, Dr. Angelina Davis, talks about the pharmacokinetics of antibiotics in patients with obesity. The article reviewed in this episode can be found here: https://pubmed.ncbi.nlm.nih.gov/40383125/

For more information about DASON, please visit: https://dason.medicine.duke.edu/

Join DASON Clinical Pharmacist Liaison Jeannette Bouchard as she speaks with Dr. Nick Turner, lead author of the DOTS randomized clinical trial, about the potential of dalbavancin as a simplified treatment for Staphylococcus aureus bacteremia. They discuss the trial’s findings, its implications for clinical practice, and whether two doses can truly replace weeks of IV antibiotics. The materials reviewed in this episode can be found here: https://dason.medicine.duke.edu/blog/new-rules-old-infections-what-dots-trial-tells-us

For more information about DASON, please visit: https://dason.medicine.duke.edu

In this episode, Dr. Melissa Johnson, one of our DASON Clinical Pharmacist Liaisons, talks with Dr. Kim Claeys, from the University of Maryland, about her recent work on the implementation diagnostic stewardship to improve UTI antibiotic use. The two publications referenced in this episode can be found here: https://pubmed.ncbi.nlm.nih.gov/40720743/ and here: https://pubmed.ncbi.nlm.nih.gov/37424224/

For more information about DASON, please visit: https://dason.medicine.duke.edu/

In this episode of the DASON Digest podcast, DASON Clinical Pharmacist Liaison, Dr. April Dyer, talks to us about an article in Antimicrobial Stewardship & Healthcare Epidemiology entitled "Implementation and performance of a nurse administered modified PEN-FAST clinical decision rule in the electronic health record." The article can be found here: https://pubmed.ncbi.nlm.nih.gov/40697885/

For more information about DASON, please visit: https://dason.medicine.duke.edu/